Table 2.

Cysticidal efficacy of different antiparasitic regimens for porcine cysticercosis*

Group description	Group	Viable cysts in muscle†				Viable cysts in brain
		Median (range)	P‡	P§	Efficacy, %	Median (range)	P‡	P§	Efficacy, %
No treatment	7	7,078 (2,072–11,746)	Ref.	Ref.	Reference	25 (16–53)	Ref.	Ref.	Reference
PZQ alone	2	6,515 (2,260–7,985)	0.873	0.09	8.0	46 (6–82)	0.631	0.07	0
Prednisone	6	5,401 (2,121–10,926)	1.00	0.02	23.7	38 (26–54)	0.273	0.02	0
NZX	5	9,433 (7,433–12,731)	0.423	0.01	0	18 (8–54)	0.631	0.12	28
OFZ	4	0 (0–0)	0.003	0.90	100	10 (1–13)	0.055	0.34	60
ABZ + PDN	1	0 (0–0)	0.004	0.90	100	0 (0–4)	0.017	0.39	100
ABZ + PZQ + PDN	3	0 (0–0)	0.005	0.90	100	0 (0–0)	0.009	0.41	100
½ ABZ + PZQ + PDN	8	0 (0–0)	0.002	0.90	100	0 (0–1)	0.007	0.34	100
ABZ + PZQ + 2 PDN	9	0 (0–0)	0.002	0.90	100	0 (0–1)	0.007	0.41	100

^*Ref. = referent; PZQ = praziquantel; NZX = nitazoxanide; OFZ = oxfendazole; ABZ = albendazole; PDN = prednisone.

^†Numbers of cysts in muscle are adjusted by weight.

^‡Mann-Whitney test (compared with the reference group).

^§Power.